Dear Wefunder investors,

Our Wefunder crowdfunding campaign has only been public for 1 week and we have already surpassed $500k in commitments!

Outside of Wefunder, we have raised an additional $450,000 from both existing angel investors who are re-investing and new angel investors, many of whom are hedge fund managers with deep biotech investing expertise. 

This brings our total raise for this round to $1,000,000!

We're looking to keep the momentum going in the coming weeks. Our crowdfunding campaign is currently scheduled to close on April 30th, and we are hoping to surpass the $1m mark on Wefunder by then. We are excited to have you join us in building the next generation of patient-centric healthcare infrastructure. 

P.S.

In case you missed it, here is a recent NYT article about clinical trials moving to the home:  https://www.nytimes.com/2021/02/18/health/clinical-trials-pandemic.html